Compared with the WT -AKI- CKD group, C3, TLR4, NFκB-P65 in the C3−/−-AKI-CKD group considerably decreased (P < 0.01) (Fig. 3a–d). This evidence concerns the gene NFKB1 and chronic kidney disease.